Veralox Therapeutics Announces Closing Of $16.6 Million Series A Financing And...
By Veralox Therapeutics | June 16, 2021
FREDERICK, Md., June 16, 2021 -- Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced the closing of a $16.6 million Series A financing. The round... Read more
Betamore & FITCI Expand Founder City
Pitch Competition Deadline Extended & Final Celebration Moved to Fall 2021
By April Bartel, FITCI | May 20, 2021
Baltimore, MD and Frederick, MD: Founder City, an impactful, hybrid conference-event created in collaboration by Betamore and Frederick Innovative Technology Center, Inc. (FITCI) has expanded its weekly programming and is extending its pitch competition deadline, thanks to strong support from... Read more
Coinbase adds Tellor, a Frederick-based cryptocurrency startup
By April Bartel, FITCI | May 19, 2021
Frederick MD – There’s been a lot of buzz about cryptocurrency, Bitcoin, and NFTs (non-fungible tokens) these days, and even small, mainstream investors are taking note, but one Maryland startup is playing the long game. Frederick-based Tellor started in March 2019, founded by Nicholas Fett,... Read more
BioSolution Designs Raises Seed Round
BioSolution Designs closes initial Seed Round of funding to accelerate its ongoing product invention activities.
By BIOSOLUTION DESIGNS | May 05, 2021
Frederick, MD., May 5, 2021 -- BioSolution Designs, LLC, announces that initial Seed Round goals are met and full operation begins as of May 1. BSD Founder and President, Dr. Thomas Reed, will direct use of the funding to accelerate existing collaborative initiatives developed over the past year.... Read more
By April Bartel, FITCI | May 04, 2021
Frederick, MD: Santhanalakshmi Shanmugam appreciates the unique challenges women face when entering the workforce, especially in the demanding fields of science and technology. She founded Minnodi, LLC, a Maryland-based Women Owned Business focusing on IT/Pharma consulting and staffing agency... Read more
Betamore & FITCI Announce Founder City
By Betamore & FITCI | April 01, 2021
Baltimore, MD and Frederick, MD: Betamore and Frederick Innovative Technology Center, Inc. (FITCI) have announced their collaboration on a new, more impactful, hybrid conference event, Founder City. Founder City brings together into one event some of the most essential pillars of the startup... Read more
Leading diagnostics laboratory in the Caribbean selects NextGenPCR for...
Clinical implementation of ultra-fast molecular testing improves time to result and laboratory throughput
By Brian McNally, CEO of VelocidyBio | March 31, 2021
Goes, Netherlands, March 31, 2021 -- Dutch biotechnology company, Molecular Biology Systems, B.V. (MBS) has announced that Aruba’s Laboratorio di Servicio (LdS) has validated and implemented NextGenPCR for SARS-CoV-2 testing. With a single NextGenPCR system capable of producing over 1,000 results... Read more
M Power Education Records Explosive Growth During the COVID-19 Pandemic
By Ivana Shuck | March 17, 2021
Frederick, MD (March 17, 2021) – M Power Education, a Frederick-based e-learning and career training company, has experienced an explosive growth in the past year, despite the global pandemic. The company grew from three to fifteen employees and expanded their client base as well as student... Read more
Veralox Therapeutics Announces FDA Orphan Drug Designation for VLX-1005
By Jeff Strovel, Veralox CEO | January 26, 2021
FREDERICK, Md – January 26, 2021 – Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced that the U.S. Food and Drug Administration (FDA) has... Read more
Veralox Therapeutics Announces IND Submission for VLX-1005 to Treat...
By Jeff Strovel, Veralox CEO | January 12, 2021
FREDERICK, Md – January 12, 2021 – Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced it submitted an Investigational New Drug (IND)... Read more
Nanoparticle COVID-19 vaccine REVC-128 potentially induces protection starting...
By FITCI | December 03, 2020
Frederick, MD, November 2020 - ReVacc Biotech scientists have designed a multivalent nanoparticle vaccine candidate REVC-128 targeting the current predominant SARS-CoV-2 viral strain with D614G mutation. The preliminary immunogenicity study showed that REVC-128 induced ultrapotent neutralizing... Read more
Trivance Design Launches Brand New Website
By Thomas Stein, CEO, Trivance Design | October 31, 2020
Frederick, MD (October 2020) – Trivance Design, a Frederick-based 3D print shop has just announced the launch of their new friendly and easy-to-use website. The site provides information related to the process as well as capabilities of extrusion-based 3D printing that can help move client’s... Read more
Leading the charge on ‘Know your Immunity,’ VirIntel, LLC announces a...
By Kim Gordon, VirIntel | October 06, 2020
Frederick, MD (October, 2020 -- VirIntel, LLC is excited to announce a partnership with Clinical Diagnostic Laboratories (CDL), one of the top Diagnostics Lab in the DC metro area, to offer the VirIntel COVID-19 Antibody Test available immediately. VirIntel leads the charge on the "know your... Read more
Veralox Therapeutics Appoints Life Sciences Industry Veteran Alex Martin as...
By Kathie Callahan Brady | September 22, 2020
FREDERICK, Md. (September, 2020) --Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced the appointment of Alex Martin as Chairman of the Board of... Read more
NANOBIOFAB Awarded a $250,000 Defense Health Agency SBIR grant
By Kathie Callahan Brady | September 22, 2020
Frederick, MD (September 2020) - Nanobiofab, a Frederick-based nanotechnology startup, was awarded a $250,000 Defense Health Agency (DHA) SBIR Program grant for their, “Inkjet assisted Nano printing sensing platform for high-throughput flexible sensors discovery” proposal. Nanobiofab has worked... Read more
VirIntel launches VirIntel COVID-19 Antibody test, delivering superior accuracy
By Kim Gordon, VirIntel | September 16, 2020
VirIntel, LLC is the R&D focused Immuno diagnostics startup located at the Frederick Innovation Technology Center pursuing the goal of immunity intelligence. VirIntel is leading the charge on the “know your immunity” movement in response to COVID-19. About COVID-19 Testing at VirIntel ... Read more
CarrTech LLC Receives Its Fourth Patent and is Awarded $50,000 Grant by TEDCO
By Kathie Callahan Brady | July 10, 2020
Frederick, MD, July, 2020 - CarrTech LLC has been awarded $50,000 from TEDCO’s Pre-seed Builder Fund, as well as professional executive coaching services for their leadership team. This significant investment and executive support specific to medical devices, will better position the company to... Read more
The Edge Accelerator Welcomes 2020 Cohort
By Kathie Callahan Brady | July 07, 2020
Frederick, MD, July 2020 – The Community Growth Accelerator Program, The Edge, welcomed its 2020 Cohort of 14 new startup companies. Frederick Innovative Technology Center, Inc (FITCI) leadership and mentors of The Edge’s program decided to transition this year’s courses and activities to... Read more
Ultrafast RT-PCR for COVID-19 by Molecular Biology Systems draws Dutch...
Publication demonstrates updated NEXTGENPCR accelerates detection of SARS-CoV-2 RNA from clinical samples
By Brian McNally, VelocidyBio | June 30, 2020
Goes, Netherlands, June 30, 2020 -- Dutch biotechnology company, Molecular Biology Systems, B.V. (MBS) has announced a publication detailing the use of its revolutionary NEXTGENPCR endpoint thermocycler to test for SARS-CoV-2 with a one-step reverse transcription polymerase chain reaction... Read more
Mesa Science Associates and Bryn Pharma Publish Final of Three Pre-Clinical...
The third in a series of studies measured cerebrospinal fluid epinephrine pharmacokinetics, nasal mucosa effects, plasma epinephrine pharmacokinetics, and cardiovascular changes.
By Kathie Callahan Brady | June 17, 2020
FREDERICK, MD June 2020—Mesa Science Associates Inc. (MSA) and Bryn Pharma LLC published the findings from the final of three (3) pre-clinical studies conducted in beagle dogs. These studies establish that epinephrine is readily absorbed when administered intranasally and has advantages over an... Read more
